Volume 13 (2015): Issue 7 (Jul 2015)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxv–xxvii
Oncology Research Program
Pages: xxxvi
Express Scripts? Really?
By: Margaret Tempero
Pages: 827
Synergistic Interactions of Molecular and Clinical Advances for Characterizing the Myelodysplastic Syndromes
By: Peter L. Greenberg
Pages: 829–832
NCCN Evolving Through the Decades: A Continuum of Commitment and Mission
By: Al B. Benson III
Pages: 833–834
Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course
By: Jocelyn S. Chapman, Saurabh Asthana, Lindsay Cade, Matthew T. Chang, Zhen Wang, Charles J. Zaloudek, Stefanie Ueda, Eric A. Collisson, and Barry S. Taylor
Pages: 835–845
Head and Neck Cancers, Version 1.2015
By: David G. Pfister, Sharon Spencer, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Robert L. Foote, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Thomas McCaffrey, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Cristina P. Rodriguez, Sandeep Samant, Jatin P. Shah, Randal S. Weber, Gregory T. Wolf, Frank Worden, Sue S. Yom, Nicole McMillian, and Miranda Hughes
Pages: 847–856
A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer
By: Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, and Y. Nancy You
Pages: 865–872
A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study
By: Muhammad Shaalan Beg, Sadia Saleem, Aslan Turer, Colby Ayers, James A. de Lemos, Amit Khera, Philipp E. Scherer, and Susan G. Lakoski
Pages: 873–878
Breast Cancer Risk Reduction, Version 2.2015
By: Therese B. Bevers, John H. Ward, Banu K. Arun, Graham A. Colditz, Kenneth H. Cowan, Mary B. Daly, Judy E. Garber, Mary L. Gemignani, William J. Gradishar, Judith A. Jordan, Larissa A. Korde, Nicole Kounalakis, Helen Krontiras, Shicha Kumar, Allison Kurian, Christine Laronga, Rachel M. Layman, Loretta S. Loftus, Martin C. Mahoney, Sofia D. Merajver, Ingrid M. Meszoely, Joanne Mortimer, Lisa Newman, Elizabeth Pritchard, Sandhya Pruthi, Victoria Seewaldt, Michelle C. Specht, Kala Visvanathan, Anne Wallace, Mary Ann Bergman, and Rashmi Kumar
Pages: 880–915
Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative
By: Rowan T. Chlebowski, Aaron K. Aragaki, and Garnet L. Anderson
Pages: 917–924
Barriers to the Use of Breast Cancer Risk Reduction Therapies
By: Arvind Bambhroliya, Mariana Chavez-MacGregor, and Abenaa M. Brewster
Pages: 927–935
Theorist's Toy: Equipoise
By: Daniel P. Kronish and Richard T. Penson
Pages: 936–938
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms
By: Venkata K. Pokuri, Houman Nourkeyhani, Bodie Betsy, Laurie Herbst, Marcus Sikorski, Edward Spangenthal, Andrew Fabiano, and Saby George
Pages: e49–e55
  • Collapse
  • Expand